Health Care · Services-Medical Laboratories · Nasdaq · CIK 1534969 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $2.05Day +0.99%Mkt cap $98M1Y −29.3%Off 52W high −48.1%Vol (1Y) 78.8%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,109 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.5% of sh out |
| Days to cover6.8d |
| 13F net flow (QoQ)−0.80% |
| Top-10 13F concentration90.6% |
| Next report (est.)2026-08-05 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$57,000 |
| Earnings (TTM)-$32.1M |
| ROE−51.8% |
| Net margin−39417.3% |
| ROIC−50.1% |
| Sales growth 3Y−32.9% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−30.5% |
| 1Y−29.3% |
| 3Y−30.0% |
| Since incept. (ann.)−28.4% |
Total return through 2026-07-29 · series begins 2021-08-13. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)78.8% |
| Ann. volatility (3Y)140.5% |
| Sharpe (1Y)−0.17 |
| Sharpe (3Y)0.41 |
| Max drawdown (1Y)−57.6% |
| Max drawdown (3Y)−87.3% |
| Beta (3Y vs SPY)1.82 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 5.5M | $11M | 11.54% | +0.0% |
| Whetstone Capital Advisors, LLC | 3.3M | $7M | 6.94% | −4.4% |
| Aberdeen Group plc | 2.6M | $5M | 5.35% | +11.9% |
| PSP Research LLC | 2.4M | $5M | 5.03% | new |
| Vivo Capital, LLC | 1.7M | $3M | 3.46% | +0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.2M | $2M | 2.53% | new |
| CAPTRUST FINANCIAL ADVISORS | 536,761 | $1M | 1.13% | −0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 363,617 | $738,511 | 0.76% | +8.7% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-06 | −$0.17 | — | $14,000 | −63.2% |
| 2025-12-31 | 2026-03-18 | — | — | $10,000 | −58.3% |
| 2025-09-30 | 2025-11-13 | −$0.16 | — | $16,000 | −44.8% |
| 2025-06-30 | 2025-08-06 | −$0.16 | — | $17,000 | −29.2% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-05 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
